Freedberg KA - Search Results

1

Assessing the performance of a computer-based policy model of HIV and AIDS.

Rydzak CE, Cotich KL, Sax PE, Hsu HE, Wang B, Losina E, Freedberg KA, Weinstein MC, Goldie SJ; CEPAC Investigators. Rydzak CE, et al. Among authors: freedberg ka. PLoS One. 2010 Sep 9;5(9):e12647. doi: 10.1371/journal.pone.0012647. PLoS One. 2010. PMID: 20844741 Free PMC article.

2

AIDS among the homeless of Boston: a cohort study.

Lebow JM, O'Connell JJ, Oddleifson S, Gallagher KM, Seage GR 3rd, Freedberg KA. Lebow JM, et al. Among authors: freedberg ka. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Mar 1;8(3):292-6. doi: 10.1097/00042560-199503010-00011. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7859142

3

The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patients.

Scharfstein JA, Paltiel AD, Freedberg KA. Scharfstein JA, et al. Among authors: freedberg ka. Med Decis Making. 1997 Oct-Dec;17(4):373-81. doi: 10.1177/0272989X9701700402. Med Decis Making. 1997. PMID: 9343795

4

The cost-effectiveness of preventing AIDS-related opportunistic infections.

Freedberg KA, Scharfstein JA, Seage GR 3rd, Losina E, Weinstein MC, Craven DE, Paltiel AD. Freedberg KA, et al. JAMA. 1998 Jan 14;279(2):130-6. doi: 10.1001/jama.279.2.130. JAMA. 1998. PMID: 9440663

5

A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection.

Paltiel AD, Scharfstein JA, Seage GR 3rd, Losina E, Goldie SJ, Weinstein MC, Craven DE, Freedberg KA. Paltiel AD, et al. Among authors: freedberg ka. Med Decis Making. 1998 Apr-Jun;18(2 Suppl):S93-105. doi: 10.1177/0272989X98018002S11. Med Decis Making. 1998. PMID: 9566470

6

The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.

Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KA. Goldie SJ, et al. Among authors: freedberg ka. Ann Intern Med. 1999 Jan 19;130(2):97-107. doi: 10.7326/0003-4819-130-2-199901190-00003. Ann Intern Med. 1999. PMID: 10068381

7

Cost effectiveness of prophylaxis for opportunistic infections in AIDS. An overview and methodological discussion.

Freedberg KA, Paltiel AD. Freedberg KA, et al. Pharmacoeconomics. 1998 Aug;14(2):165-74. doi: 10.2165/00019053-199814020-00005. Pharmacoeconomics. 1998. PMID: 10186457 Review.

8

The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.

Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. Goldie SJ, et al. Among authors: freedberg ka. JAMA. 1999 May 19;281(19):1822-9. doi: 10.1001/jama.281.19.1822. JAMA. 1999. PMID: 10340370

9

Are European-specific guidelines needed for prevention of opportunistic infections in HIV-1?

Yazdanpanah Y, Goldie SJ, Salamon R, Mouton Y, Freedberg KA. Yazdanpanah Y, et al. Among authors: freedberg ka. Lancet. 1999 Oct 9;354(9186):1305-6. doi: 10.1016/S0140-6736(05)76083-9. Lancet. 1999. PMID: 10520668 No abstract available.

10

Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men.

Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Palefsky JM. Goldie SJ, et al. Among authors: freedberg ka. Am J Med. 2000 Jun 1;108(8):634-41. doi: 10.1016/s0002-9343(00)00349-1. Am J Med. 2000. PMID: 10856411

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

365 results

Search Page

Filters